You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 175 A Fas-4–1BB immunomodulatory fusion protein converts a pro-death to a pro-survival signal, enhancing T cell function and efficacy of adoptive cell therapy in murine models of AML and pancreatic cancer

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Cellular therapies
175 A Fas-4–1BB immunomodulatory fusion protein converts a pro-death to a pro-survival signal, enhancing T cell function and efficacy of adoptive cell therapy in murine models of AML and pancreatic cancer

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020125012
Dec 20201605
Jan 20212803
Feb 2021803
Mar 20213005
Apr 20212403
May 2021404
Jun 2021004
Jul 2021007
Aug 2021008
Sep 2021005
Oct 20214019
Nov 20214019
Dec 20212201
Jan 20221400
Feb 20221101
Mar 20221401
Apr 20224802
May 20221401
Jun 20221903
Jul 20223603
Aug 20223102
Sep 20222101
Oct 20221201
Nov 20221901
Dec 20222801
Jan 20233402
Feb 20232002
Mar 20232402
Apr 20231402
May 20231400
Jun 20231802
Jul 20231204
Aug 20231001
Sep 20231402
Oct 20231602
Nov 20231803
Dec 20234602
Jan 20242201
Feb 20243200
Mar 20243400
Apr 20242204
May 20242003
Jun 20241801
Jul 20242601
Aug 20242003
Sep 20241401
Oct 20242404
Nov 2024804
Dec 20242005
Jan 20251006
Feb 2025807
Mar 20250014
Apr 2025004
May 2025003
Jun 2025004
Total10500204